We are very pleased to welcome back the International Precision Oncology Congress, which will be held on the 54th Floor of the spectacular venue, the Bow Tower  in Calgary, AB on November 7 & 8, 2024.

The POET Congress has been held since 2017, each year being a great success. The feedback we received from the last in-person meeting held in 2020, along with the monthly POET National Virtual Molecular Rounds confirms an increased interest in cutting-edge precision oncology.

The International Precision Oncology Congress’ 2024 objective is to create a forum for dialogue between oncologists, molecular researchers, biopharma leaders, data analysts, clinical trial design specialists and real-world expert perspectives. Attendees will learn about cutting edge biomarker research, signal and clinical trial outcomes in targeted and immune-oncology therapeutics. There will be keynote presentations on new and relevant data in precision oncology from renowned Canadian, US and UK speakers.

Learning Objectives:

1. As a result of attending this program, the participant will be able to identify novel polyomic interrogatives to consider optimal treatment approaches when incorporating immunotherapeutics and targeted agents in cancer management.
2. As a result of attending this program, the participant will be able to apply principles of precision oncology clinical trial design.
3. As a result of attending this program, the participant will be able to understand key issues facing precision oncology adoption in a traditional health care system.

We look forward to seeing you at this very informative meeting,

Best regards,

POET Co-Chairs